Status of liver fibrosis evaluated by aspartate aminotransferase to platelet ratio in patients with non-alcoholic fatty liver disease
10.3760/cma.j.issn.1671-7368.2017.03.011
- VernacularTitle:非酒精性脂肪性肝病患者2 054例肝纤维化状况的评估
- Author:
Annan LIU
;
Xiaolan ZHAO
;
Zhiheng CHEN
;
Qun ZHANG
;
Hai'ou HONG
;
Yu WANG
;
Shouqing HUANG
;
Qibin WANG
;
Yanni XIA
;
Ling ZHU
- Keywords:
Fatty liver;
Diagnosis;
Aspartate aminotransferase-to-platelet ratio index;
Fibrosis
- From:
Chinese Journal of General Practitioners
2017;16(3):219-223
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the prevalence and risk factors of progressive liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).Methods A total of 2 054 subjects who underwent health check up and were diagnosed as NAFLD in 9 institutions were included in the study.Blood routine and biochemical findings were collected to calculate aspartate aminotransferase-to-platelet ratio index (APRI).Subjects were divided into three groups according to diagnostic threshold of liver fibrosis:APRI ＜0.43 group,APRI 0.43-0.53 group and APRI ≥ 0.54 group.The correlation between APRI and biochemical variables was analyzed,and the risk factors of progressive fibrosis were also analyzed.Results Among 2 054 subjects (male/female 1 598/456) there were 61 cases with APRI ≥ 0.98 (2.97％,progressive fibrosis),318 with APRI ≥0.54 (15.48％),1 475 with APRI ＜ 0.43 (71.81％),261 with APRI 0.43-0.53 (12.71％).Logistic stepwise regression analysis showed that TG (P =0.002,OR =1.095,95％CI:1.033-1.161),2 hPG(P =0.000,OR =1.103,95％ CI:1.058-1.151,BUN(P =0.034,OR =1.215,95 ％ CI:1.014-1.454) were risk factors,and H DL-C (P =0.034,OR =0.353,95 ％ CI:O.135-0.924) was a protective factor for the progression of fibrosis.Conclusion The progressive fibrosis in patients with NAFLD is closely associated to blood glucose and lipid metabolism disorder.
